Global Benign Prostatic Hyperplasia (BPH) Drugs Market Data Survey Report 2015-2025
- HEY3417593
- 73 Pages
- January 2020
- Healthcare
The global Benign Prostatic Hyperplasia (BPH) Drugs market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major End-Use
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
Astellas Pharma
Eli Lilly
GlaxoSmithKline
Sanofi
ADC Therapeutics
Bayer HealthCare
Bristol-Myers Squibb
Valeant Pharmaceuticals
Endo Pharmaceuticals
Foresee Pharmaceuticals
Madrigal Pharmaceuticals
Merck
Novartis
Spectrum Pharmaceuticals
Takeda Pharmaceuticals
Teva
Advaxis
ANI Pharmaceuticals
BHR Pharma
Major applications as follows:
Hospitals
Clinics
Others
Major Type as follows:
Alpha-blocker
Phosphodiesterase Type-5 Inhibitors
5-alpha-Reductase Inhibitors
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of End-Use
1.1.4 Scope of Product Type
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
Fig Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size and CAGR 2015-2019 (Million USD)
Fig Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size and CAGR 2015-2019 (Volume)
Fig Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast and CAGR 2020-2025 (Million USD)
Fig Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast and CAGR 2020-2025 (Volume)
2 Regional Market
2.1 Regional Sales
Tab Regional Sales Revenue 2015-2019 (Million USD)
Tab Regional Sales Volume 2015-2019 (Volume)
2.2 Regional Demand
Tab Regional Demand and CAGR List 2015-2019 (Million USD)
Tab Regional Demand and CAGR List 2015-2019 (Volume)
Tab Regional Demand Forecast and CAGR 2020-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2020-2025 (Volume)
2.3 Regional Trade
Tab Regional Export 2015-2019 (Million USD)
Tab Regional Export 2015-2019 (Volume)
Tab Regional Import 2015-2019 (Million USD)
Tab Regional Import 2015-2019 (Volume)
3 Key Manufacturers
3.1 Astellas Pharma
3.1.1 Company Information
Tab Company Profile List of Astellas Pharma
3.1.2 Product & Services
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Astellas Pharma
3.1.4 Recent Development
3.2 Eli Lilly
3.2.1 Company Information
Tab Company Profile List of Eli Lilly
3.2.2 Product & Services
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Eli Lilly
3.2.4 Recent Development
3.3 GlaxoSmithKline
3.3.1 Company Information
Tab Company Profile List of GlaxoSmithKline
3.3.2 Product & Services
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of GlaxoSmithKline
3.3.4 Recent Development
3.4 Sanofi
3.4.1 Company Information
Tab Company Profile List of Sanofi
3.4.2 Product & Services
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Sanofi
3.4.4 Recent Development
3.5 ADC Therapeutics
3.5.1 Company Information
Tab Company Profile List of ADC Therapeutics
3.5.2 Product & Services
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of ADC Therapeutics
3.5.4 Recent Development
3.6 Bayer HealthCare
3.6.1 Company Information
Tab Company Profile List of Bayer HealthCare
3.6.2 Product & Services
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Bayer HealthCare
3.6.4 Recent Development
3.7 Bristol-Myers Squibb
3.7.1 Company Information
Tab Company Profile List of Bristol-Myers Squibb
3.7.2 Product & Services
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Bristol-Myers Squibb
3.7.4 Recent Development
3.8 Valeant Pharmaceuticals
3.8.1 Company Information
Tab Company Profile List of Valeant Pharmaceuticals
3.8.2 Product & Services
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Valeant Pharmaceuticals
3.8.4 Recent Development
3.9 Endo Pharmaceuticals
3.9.1 Company Information
Tab Company Profile List of Endo Pharmaceuticals
3.9.2 Product & Services
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Endo Pharmaceuticals
3.9.4 Recent Development
3.10 Foresee Pharmaceuticals
3.10.1 Company Information
Tab Company Profile List of Foresee Pharmaceuticals
3.10.2 Product & Services
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Foresee Pharmaceuticals
3.10.4 Recent Development
3.11 Madrigal Pharmaceuticals
3.11.1 Company Information
Tab Company Profile List of Madrigal Pharmaceuticals
3.11.2 Product & Services
3.11.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Madrigal Pharmaceuticals
3.11.4 Recent Development
3.12 Merck
3.12.1 Company Information
Tab Company Profile List of Merck
3.12.2 Product & Services
3.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Merck
3.12.4 Recent Development
3.13 Novartis
3.13.1 Company Information
Tab Company Profile List of Novartis
3.13.2 Product & Services
3.13.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Novartis
3.13.4 Recent Development
3.14 Spectrum Pharmaceuticals
3.14.1 Company Information
Tab Company Profile List of Spectrum Pharmaceuticals
3.14.2 Product & Services
3.14.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Spectrum Pharmaceuticals
3.14.4 Recent Development
3.15 Takeda Pharmaceuticals
3.15.1 Company Information
Tab Company Profile List of Takeda Pharmaceuticals
3.15.2 Product & Services
3.15.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Takeda Pharmaceuticals
3.15.4 Recent Development
3.16 Teva
3.16.1 Company Information
Tab Company Profile List of Teva
3.16.2 Product & Services
3.16.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Teva
3.16.4 Recent Development
3.17 Advaxis
3.17.1 Company Information
Tab Company Profile List of Advaxis
3.17.2 Product & Services
3.17.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Advaxis
3.17.4 Recent Development
3.18 ANI Pharmaceuticals
3.18.1 Company Information
Tab Company Profile List of ANI Pharmaceuticals
3.18.2 Product & Services
3.18.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of ANI Pharmaceuticals
3.19 BHR Pharma
3.19.1 Company Information
Tab Company Profile List of BHR Pharma
3.19.2 Product & Services
3.19.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of BHR Pharma
4 Major End-Use
4.1 Hospitals
4.1.1 Overview
Tab Summary of Consumption Distribution of Hospitals
4.1.2 Hospitals Market Size and Forecast
Fig Hospitals Market Size and CAGR 2015-2019 (Million USD)
Fig Hospitals Market Size and CAGR 2015-2019 (Volume)
Fig Hospitals Market Forecast and CAGR 2020-2025 (Million USD)
Fig Hospitals Market Forecast and CAGR 2020-2025 (Volume)
4.2 Clinics
4.2.1 Overview
Tab Summary of Consumption Distribution of Clinics
4.2.2 Clinics Market Size and Forecast
Fig Clinics Market Size and CAGR 2015-2019 (Million USD)
Fig Clinics Market Size and CAGR 2015-2019 (Volume)
Fig Clinics Market Forecast and CAGR 2020-2025 (Million USD)
Fig Clinics Market Forecast and CAGR 2020-2025 (Volume)
4.3 Others
4.3.1 Overview
Tab Summary of Consumption Distribution of Others
4.3.2 Others Market Size and Forecast
Fig Others Market Size and CAGR 2015-2019 (Million USD)
Fig Others Market Size and CAGR 2015-2019 (Volume)
Fig Others Market Forecast and CAGR 2020-2025 (Million USD)
Fig Others Market Forecast and CAGR 2020-2025 (Volume)
5 Market by Type
5.1 Alpha-blocker
5.1.1 Overview
Tab Product Overview of Alpha-blocker
5.1.2 Alpha-blocker Market Size and Forecast
Fig Alpha-blocker Market Size and CAGR 2015-2019 (Million USD)
Fig Alpha-blocker Market Size and CAGR 2015-2019 (Volume)
Fig Alpha-blocker Market Forecast and CAGR 2020-2025 (Million USD)
Fig Alpha-blocker Market Forecast and CAGR 2020-2025 (Volume)
5.2 Phosphodiesterase Type-5 Inhibitors
5.2.1 Overview
Tab Product Overview of Phosphodiesterase Type-5 Inhibitors
5.2.2 Phosphodiesterase Type-5 Inhibitors Market Size and Forecast
Fig Phosphodiesterase Type-5 Inhibitors Market Size and CAGR 2015-2019 (Million USD)
Fig Phosphodiesterase Type-5 Inhibitors Market Size and CAGR 2015-2019 (Volume)
Fig Phosphodiesterase Type-5 Inhibitors Market Forecast and CAGR 2020-2025 (Million USD)
Fig Phosphodiesterase Type-5 Inhibitors Market Forecast and CAGR 2020-2025 (Volume)
5.3 5-alpha-Reductase Inhibitors
5.3.1 Overview
Tab Product Overview of 5-alpha-Reductase Inhibitors
5.3.2 5-alpha-Reductase Inhibitors Market Size and Forecast
Fig 5-alpha-Reductase Inhibitors Market Size and CAGR 2015-2019 (Million USD)
Fig 5-alpha-Reductase Inhibitors Market Size and CAGR 2015-2019 (Volume)
Fig 5-alpha-Reductase Inhibitors Market Forecast and CAGR 2020-2025 (Million USD)
Fig 5-alpha-Reductase Inhibitors Market Forecast and CAGR 2020-2025 (Volume)
6 Price Overview
6.1 Price by Manufacturers
Tab Different Products Prices List of Major Manufacturers
6.2 Price by End-Use
Tab Different Products Prices List of End-Use
6.3 Price by Type
Tab Different Products Prices List of Produt Type
7 Conclusion
Tab Regional Sales Revenue 2015-2019 (Million USD)
Tab Regional Sales Volume 2015-2019 (Volume)
Tab Regional Demand and CAGR List 2015-2019 (Million USD)
Tab Regional Demand and CAGR List 2015-2019 (Volume)
Tab Regional Demand Forecast and CAGR 2020-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2020-2025 (Volume)
Tab Regional Export 2015-2019 (Million USD)
Tab Regional Export 2015-2019 (Volume)
Tab Regional Import 2015-2019 (Million USD)
Tab Regional Import 2015-2019 (Volume)
Tab Company Profile List of Astellas Pharma
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Astellas Pharma
Tab Company Profile List of Eli Lilly
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Eli Lilly
Tab Company Profile List of GlaxoSmithKline
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of GlaxoSmithKline
Tab Company Profile List of Sanofi
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Sanofi
Tab Company Profile List of ADC Therapeutics
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of ADC Therapeutics
Tab Company Profile List of Bayer HealthCare
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Bayer HealthCare
Tab Company Profile List of Bristol-Myers Squibb
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Bristol-Myers Squibb
Tab Company Profile List of Valeant Pharmaceuticals
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Valeant Pharmaceuticals
Tab Company Profile List of Endo Pharmaceuticals
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Endo Pharmaceuticals
Tab Company Profile List of Foresee Pharmaceuticals
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Foresee Pharmaceuticals
Tab Company Profile List of Madrigal Pharmaceuticals
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Madrigal Pharmaceuticals
Tab Company Profile List of Merck
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Merck
Tab Company Profile List of Novartis
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Novartis
Tab Company Profile List of Spectrum Pharmaceuticals
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Spectrum Pharmaceuticals
Tab Company Profile List of Takeda Pharmaceuticals
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Takeda Pharmaceuticals
Tab Company Profile List of Teva
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Teva
Tab Company Profile List of Advaxis
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of Advaxis
Tab Company Profile List of ANI Pharmaceuticals
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of ANI Pharmaceuticals
Tab Company Profile List of BHR Pharma
Tab Sales Revenue, Sales Volume, Price, Cost and Margin of BHR Pharma
Tab Summary of Consumption Distribution of Hospitals
Tab Summary of Consumption Distribution of Clinics
Tab Summary of Consumption Distribution of Others
Tab Product Overview of Alpha-blocker
Tab Product Overview of Phosphodiesterase Type-5 Inhibitors
Tab Product Overview of 5-alpha-Reductase Inhibitors
Tab Different Products Prices List of Major Manufacturers
Tab Different Products Prices List of End-Use
Tab Different Products Prices List of Produt Type
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
